Bookmark

Add to MyYahoo RSS

Crohn's Disease News

News on Crohn's Disease continually updated from thousands of sources around the net.

3 hrs ago | Medical News Today

The effectiveness of inflammatory bowel disease therapy could be prolonged by proactive monitoring

Proactive monitoring and dose adjustment of infliximab , a medication commonly used to treat inflammatory bowel disease , could improve a patient's chances of having a long-term successful response to therapy, a pilot observational study at Beth Israel Deaconess Medical Center concludes. The study, published in Inflammatory Bowel Diseases , evaluated the levels of infliximab, an antibody designed to bind to and block the effects of TNF-alpha, an inflammatory protein found in high levels in patients with IBD, such as Crohn's disease and ulcerative colitis, and numerous other inflammatory conditions such as rheumatoid arthritis and psoriasis .

Comment?

Related Topix: Medicine, Health, Ulcerative Colitis, Rheumatoid Arthritis

4 hrs ago | BioSpace

TiGenix To Participate Or Present At Key Conferences In The Second Half Of 2014

TiGenix NV , an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platform of allogeneic, expanded adipose-derived stem cells, or eASC's, in inflammatory and autoimmune diseases, announced today the list of conferences in which it will participate during the second half of 2014.

Comment?

Related Topix: Stem Cell Research, Science / Technology, Mesa, CA, World News, Austria, Health, Medicine, Arthritis, Marketing

Mon Sep 15, 2014

The Mountaineer Publishing Company

Natural Solutions to Digestive and Bowel Disorders

Learn about the causes of problems like bloating, heartburn, nausea, colitis, Crohn's disease and gall stones; discover why digestion should be first priority; and identify the missing link to natural healing. Michelle Sanderbeck, Haywood County's only doctor of naturopathy, will lead the presentation.

Comment?

Related Topix: Health

Hispanic Business

Biopharmaceutical Market - Global Industry Analysis and Forecast to...

Biopharmaceuticals are medicinal drugs produced by using biotechnology methods, such as isolation from living organisms and by the use of recombinant DNA technology. Moreover, it is also produced by using transgenic organisms, particularly animals and plant that have been genetically modified to produce drugs.

Comment?

Related Topix: Biotech, Science / Technology, Rheumatoid Arthritis, Medicine, Health, Diabetes, Infectious Diseases, Oncology

Reuters

Epirus, Ranbaxy win India approval for arthritis drug copy

Epirus Biopharmaceuticals Inc said India's drug regulator has approved its copy of a top-selling arthritis treatment, paving the way for its launch in the country early next year. The company's Indian partner, Ranbaxy Laboratories Ltd, will sell a copycat version of Johnson & Johnson's and Merck & Co Inc's infliximab, an anti-inflammatory drug with annual sales of about $6 billion.

Comment?

Related Topix: Medicine, Arthritis, Health, Rheumatoid Arthritis, Enbrel, Etanercept (generic)

BioSpace

RedHill Biopharma Ltd. To Present At The

RedHill Biopharma Ltd. , an Israeli biopharmaceutical company focused on late clinical-stage drugs for inflammatory and gastrointestinal diseases, including gastrointestinal cancers, today announced that Adi Frish, RedHill's Senior VP Business Development and Licensing, will be presenting at the 7th Annual BioPharm America International Partnering Conference, on Tuesday, September 23, 2014, at 2:45 p.m. EDT, in the Suffolk room of the Boston Marriott Copley Placein Boston, Massachusetts. A copy of the presentation to be made by Mr. Frish has been uploaded to the Company's website and may be viewed at the following web address: http://ir.redhillbio.com/events.cfm .

Comment?

Related Topix: Medicine, Cancer, Health

PhysOrg Weblog

AGA releases new tool to help GIs evaluate and treat Crohn's disease

The treatment of Crohn's disease is evolving. To help gastroenterologists better identify and manage their Crohn's disease patients, the American Gastroenterological Association has created a clinical decision tool to guide GIs in their decision-making process.

Comment?

Related Topix: Health, Gastroenterology, University of San Diego, La-Jolla, CA

Sun Sep 14, 2014

The Northern Echo

Fun Day: Andrea Meek's Charity Fun Day raising money for Crohn's Disease in Sacriston.

A CHARITY day organised by a young woman who suffers from Crohn's disease held been held in the North-East. Andrea Meek, 25, of Sacriston, near Chester-le-Street , watched her father struggle with the bowel condition but did not realise she would also one day have to fight it.

Comment?

Related Topix: Health

PR-inside.com

New Report Available: TxCell SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Txcell SA is a biotechnology company. The company develops cell-based immunotherapy using antigen specific regulatory T-cells for chronic inflammatory and autoimmune diseases.

Comment?

Related Topix: Health, Medicine, Rheumatoid Arthritis

Sat Sep 13, 2014

CiteULike

The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease.

Interleukin- 35 and IL-37 are newly discovered immune-suppressing cytokines. They have been described in inflammatory diseases such as collagen-induced arthritis and asthma.

Comment?

Related Topix: Ulcerative Colitis, Health

Thu Sep 11, 2014

State Press

Student shines as campaign manager for Tempe politician

Political science senior Austin Stumpf worked as the campaign manager for Lauren Kuby, who ran successfully for Tempe City Council in August. Political science senior Austin Stumpf helped secure an election during one of the biggest and most painful moments of his life.

Comment?

Related Topix: Health

Newswise

Proactive Monitoring Of Inflammatory Bowel Disease Therapy Could Prolong Effectiveness

Proactive monitoring and dose adjustment of infliximab, a medication commonly used to treat inflammatory bowel disease , could improve a patient's chances of having a long-term successful response to therapy, a pilot observational study at Beth Israel Deaconess Medical Center concludes. The study, published in the Inflammatory Bowel Disease Journal , evaluated the levels of infliximab, an antibody designed to bind to and block the effects of TNF-alpha, an inflammatory protein found in high levels in patients with IBD, such as Crohn's disease and ulcerative colitis, and numerous other inflammatory conditions such as rheumatoid arthritis and psoriasis.

Comment?

Related Topix: Beth Israel Deaconess Medical Center, Hospital Administration, Healthcare Industry, Health, Ulcerative Colitis, Rheumatoid Arthritis

BioSpace

Analyst: Celgene's New Crohn??'s Drug Facing Fibrotic Challenges

September 11, 2014 By Riley McDermid , BioSpace.com Breaking News Sr. Editor The new Crohn's disease drug Celgene bought the rights to last April for $710 million is unlikely to be a "once daily" product due to the theoretical risk of fibrotic changes with long term exposure, Chief Financial Officer Peter Kellogg told analysts Wednesday. Mark Schoenebaum, a biotech and pharmaceuticals analyst and medical doctor for ISI Group, said in a report that Kellogg said Celgene remains committed to testing GED-0301, an oral antisense DNA oligonucleotide targeting Smad7 mRNA for the treatment of moderate-to-severe Crohn's disease and other indications.

Comment?

Related Topix: Biotech, Celgene, Medicine, Healthcare Industry, Health, Startups, BioSpace.com

Tue Sep 09, 2014

This is Local London

Cycling team raises thousands for charity

A group of amateur cyclists who rode all way from Harrow to Paris have raised more than A 5,500 for charity. The team called The Bombay Bicycle Club, made up of friends from the Stanmore and Kingsbury areas, took on the four-day challenge last week.

Comment?

Related Topix: United Kingdom, Greater London County, England, Health

Watertown Daily Times

Family of Castorland boy planning fundraisers for Crohna s research

The family of a Castorland boy fighting Crohn's disease is planning a bake sale and fun day to raise money to help find a cure. “He's a little fighter,” Joyce M. Brouty said of her son, Levi J., a seventh-grader at Lowville Academy and Central School.

Comment?

Related Topix: Castorland, NY, Health, Lowville, NY

Alabama Live

Crohn's & Colitis Foundation's Take Steps walk to be held Sunday at Big Spring Park in Huntsville

HUNTSVILLE, Alabama -- The Alabama-Northwest Florida Chapter of the Crohn's & Colitis Foundation of America will hold one of its Take Steps fundraisers this weekend in Big Spring Park. The walk will begin at 4 p.m. Sunday at the park.

Comment?

Related Topix: Medicine, Health, Colitis, Huntsville, AL

Braintree and Witham Times

I won't let cripping condition stop me taking on Himalayas

A FITNESS fanatic is set to embark on an 18-day mountain trek after being diagnosed with a crippling condition. Emmie Brown, 26, from Basildon , will travel through beautiful valleys, dense forests and rivers on her amazing journey to Mount Everest's base camp.

Comment?

Related Topix: World News, Essex County, England, United Kingdom, Nepal Travel, Travel, Asia, Nepal, Asia Travel, Marketing, Health

Patch.com

Bernards: First Annual 'CURE For IBD' 5K and 1 Mile Fun Run, Sept. 28

CURE for IBD Announces its first annual 5K and 1 Mile Fun Run to benefit the Crohn's and Colitis Foundation of America on Sunday, September 28, 2014 at Mountain Park, Bernards Township. CURE for IBD is a local charitable organization which partners with business and community residents to raise funds for research and awareness of debilitating diseases affecting 1.5 million Americans each year.

Comment?

Related Topix: Health, Medicine, Colitis, Lake Placid, NY

Mon Sep 08, 2014

NewsTarget.com

Inflammatory bowel disease drugs can increase leukemia risk by 700%

One class of drugs used to treat inflammatory bowel disease may increase the risk of blood and bone marrow diseases sevenfold, according to a study conducted by researchers from the University Hospital of Nancy-Brabois in France and published in the journal Clinical Gastroenterology and Hepatology . The drugs studied, known as thiopurines, are intended to provide symptomatic relief and reduce flare-ups by reducing inflammation.

Comment?

Related Topix: Leukemia, Health, Ulcerative Colitis

Hispanic Business

European Medicines Agency accepts TiGenix Paediatric Investigation Plan for Cx601

An accepted PIP is a requirement for the filing for marketing authorisation of a new medicinal product with the EMA. It describes how a company intends to evaluate the use of the new product in children.

Comment?

Related Topix: Science / Technology, Stem Cell Research, Health, Marketing

•••
•••
•••
•••
•••
•••
•••